Educational content only. Not medical advice. Consult a healthcare provider for personal guidance.
Restless Legs Syndrome

Treating Restless Legs Syndrome: What the Latest Guidelines Recommend

7 min readPublished April 1, 2026

Written and medically reviewed by Matthew Viereck, MD, board-certified sleep medicine physician · Reviewed October 2026 · Editorial standards

Based on the 2025 AASM Clinical Practice Guideline for Treatment of RLS and PLMD and the 2026 Mayo Clinic Proceedings RLS management algorithm

Illustration of a prescription bottle, colored pills, and an iron supplement representing treatment options for restless legs syndrome

The short answer

  • Get your iron checked. Low iron is the most common treatable contributor to restless legs. Ask for a ferritin and transferrin saturation blood test. For RLS, iron treatment is recommended when ferritin is 75 or below (or transferrin saturation is under 20%), and IV iron is now indicated up to a ferritin of 300 when transferrin saturation is under 45%. Both are well above the level most labs flag as low. Many people improve substantially with iron alone.
  • The preferred medicines have changed. Gabapentin-type medicines (gabapentin, Horizant, Lyrica) are now the first choice. The 2025 guideline suggests against the standard use of the older dopamine drugs, ropinirole (Requip), pramipexole (Mirapex) and the rotigotine patch (Neupro), because over time they can make RLS worse.
  • Already taking Requip or Mirapex? Don't stop on your own, but do talk to your doctor, especially if symptoms now start earlier in the day or have spread to your arms. What to do if you take one now.
  • Tonight: skip evening caffeine and alcohol, and check your medicine cabinet. Sedating antihistamines (Benadryl and most "PM" sleep aids) and some antidepressants make restless legs worse. Jump to tonight's relief measures.

Treatment Has Changed for the Better

If restless legs are wrecking your evenings, there is genuinely good news: the way doctors treat restless legs syndrome (RLS) was overhauled in 2025, and the new approach works better and is safer over the long term.

The American Academy of Sleep Medicine (AASM), the professional body that sets treatment standards for sleep doctors, published new guidelines that reversed more than a decade of practice. The medications that were standard for years, ropinirole (Requip) and pramipexole (Mirapex), are no longer first-line: the guideline now suggests against their standard use, because with long-term daily use they often backfire and make symptoms worse, a problem called augmentation. In their place, the guideline puts iron first, followed by gabapentin-type medications.

This article walks through the current recommended approach: what you can do tonight, what to ask your doctor to test, and which medications are now preferred. The same guideline also covers periodic limb movement disorder (PLMD), a related condition in which the legs move repeatedly during sleep, addressed near the end.

What You Can Do Tonight

Before any prescription, there are things that help right away:

  • Cut evening caffeine and alcohol. Both reliably worsen RLS, alcohol especially later in the night
  • Check your medicine cabinet. Diphenhydramine (Benadryl) and doxylamine, the sedating antihistamines in most over-the-counter "PM" sleep aids, commonly aggravate restless legs. If you take one to sleep, it may be feeding the problem
  • Move, then stretch. A short walk followed by calf and hamstring stretches before bed provides relief for many people
  • Try heat, massage, or distraction. A warm bath, leg massage, or an engaging mental activity (puzzles, conversation) can quiet symptoms enough to fall asleep

These measures complement, but don't replace, the medical evaluation below. The full lifestyle section later in this article covers each in more detail, including prescription medications that can silently worsen RLS.

Step 1: Check and Treat Iron Deficiency

Iron assessment is now the first step in treating RLS, whatever the severity. Iron is needed to make dopamine, the brain chemical that helps control movement, and many people with RLS have too little iron in key brain regions even when ordinary blood counts look normal.

What to test. The 2025 AASM guideline asks clinicians to check iron studies regularly in everyone with clinically significant RLS, ideally drawn in the morning after at least 24 hours without iron pills or iron-rich foods:

  • Serum ferritin, the body's iron store
  • Transferrin saturation (TSAT), calculated from serum iron and total iron-binding capacity

When to treat. For adults with RLS:

  • Ferritin 75 or below, or TSAT under 20%: oral or IV iron
  • Ferritin between 75 and 300, with TSAT under 45%: IV iron, because oral iron is poorly absorbed at these levels

The AASM guideline set the IV range at 75 to 100. The 2026 RLS management algorithm in Mayo Clinic Proceedings, which drew on newer studies, extends it to 300 for chronic persistent RLS, as long as transferrin saturation is under 45%.

These cutoffs are much higher than the ones used for anemia. A ferritin of 40 may be "normal" on a lab report and still be too low for someone with RLS.

How. Oral iron (ferrous sulfate, often taken every other day) is inexpensive but slow, can take months to raise ferritin, and often upsets the stomach. IV iron works faster and bypasses the gut. IV ferric carboxymaltose received a strong recommendation; IV ferumoxytol, IV low molecular weight iron dextran and oral ferrous sulfate received conditional ones. Recheck iron after treatment and whenever symptoms return.

The full detail on testing, dosing, absorption and IV options is in The Role of Iron in Restless Legs Syndrome.

Step 2: Medications: What the Guidelines Recommend

If correcting iron does not control symptoms well enough, medication may be needed. The 2025 guideline sorts the options clearly.

This family of medicines (alpha-2-delta ligands, the term you may see in guideline documents) is now the preferred first choice. All three received a strong recommendation:

Gabapentin

  • Typical dose range 300 to 1,800 mg, taken in the evening
  • Helps both the leg sensations and the broken sleep
  • Common side effects: drowsiness, dizziness, weight gain

Gabapentin enacarbil (Horizant)

  • An extended-release form of gabapentin, FDA-approved for RLS
  • Typical dose 600 mg once daily at about 5 p.m. with food
  • More consistent absorption than standard gabapentin

Pregabalin (Lyrica)

  • Typical dose range 150 to 450 mg, taken in the evening
  • May also help coexisting pain or anxiety
  • A Schedule V controlled substance

These medicines do not cause augmentation, the main reason they now come first.

Other Options the Guideline Supports (Conditional)

These received conditional recommendations, meaning they suit some patients more than others:

  • Opioids, such as extended-release oxycodone, at low doses for severe RLS that has not responded to other treatment, prescribed and monitored by a clinician experienced in using them for RLS
  • Bilateral high-frequency peroneal nerve stimulation, a wearable device worn on the lower legs at bedtime
  • Dipyridamole, a medicine better known for preventing blood clots, with lower-certainty evidence for RLS

Suggested Against for Standard Use: Dopamine Agonists and Levodopa

The guideline suggests against the standard use of pramipexole (Mirapex), ropinirole (Requip), the rotigotine patch (Neupro) and levodopa. They work well at first, but with daily use over months to years they can cause augmentation: symptoms start earlier in the day, come on faster at rest, spread to the arms, and need ever higher doses. The guideline leaves room for them in people who place more value on short-term relief than on the long-term risk, and many patients still take them from before the change.

How augmentation develops, the impulse control side effects, and how to come off these medicines safely are covered in Why Dopamine Agonists Are No Longer First-Line Treatment.

The guideline advises against cabergoline (a strong recommendation against), and suggests against clonazepam, bupropion, carbamazepine, valproic acid and valerian for RLS.

Lifestyle and Non-Medication Strategies

While not a substitute for medical treatment in moderate to severe RLS, lifestyle measures can provide meaningful relief and complement medication:

Activity and Exercise

  • Regular moderate exercise (walking, cycling, swimming) can reduce RLS symptoms
  • Avoid vigorous exercise close to bedtime, which may temporarily worsen symptoms
  • Stretching, particularly calf and hamstring stretches, before bed may provide relief

Sleep Hygiene

  • Maintain a consistent sleep schedule
  • Keep the bedroom cool; some patients find that cooler temperatures help
  • Avoid prolonged bedrest; get up and move if symptoms are severe

Substances to Avoid

  • Caffeine can worsen RLS symptoms. Reduce or eliminate, especially after noon
  • Alcohol often worsens symptoms, particularly later in the night
  • Nicotine is a stimulant that may exacerbate RLS
  • Antihistamines (diphenhydramine/Benadryl) commonly worsen RLS and are found in many OTC sleep aids

Medications That May Worsen RLS

Review all current medications with your doctor. The following drug classes are known to potentially trigger or worsen RLS:

  • SSRI and SNRI antidepressants (sertraline, fluoxetine, venlafaxine, duloxetine)
  • Older antihistamines (diphenhydramine, doxylamine)
  • Anti-nausea medications (metoclopramide, prochlorperazine)
  • Some antipsychotic medications
  • Lithium

If you are taking one of these medications and have RLS, discuss alternatives with your prescriber. Never stop a prescribed medication without consulting your doctor.

Comfort Measures

  • Warm baths before bed
  • Leg massage
  • Heating pads or ice packs (individual preference varies)
  • Pneumatic compression devices
  • Distraction techniques (engaging mental activity can reduce symptom awareness)
  • Weighted blankets (some patients report benefit, though evidence is limited)

Periodic Limb Movement Disorder (PLMD)

Periodic limb movement disorder is a separate diagnosis: repeated leg movements during sleep, measured on a sleep study, that disrupt sleep or cause daytime symptoms without the waking urge to move that defines RLS, and without another sleep disorder such as sleep apnea to explain them.

The evidence for treating PLMD is thin. The 2025 guideline makes only two recommendations for it, both against: triazolam (a sleep medication) and valproic acid. In practice, clinicians often check iron and look for sleep apnea and medications that can increase limb movements. Treatment is individual and best guided by a sleep specialist.

Special Situations

RLS During Pregnancy

  • Affects about 1 in 5 pregnant women, most often in the third trimester
  • Iron and folate deficiency should be assessed and treated
  • Most medications used for RLS are not recommended during pregnancy
  • Symptoms typically resolve after delivery
  • Non-medication strategies are the primary approach during pregnancy. More in Sleep During Pregnancy

RLS in Children

  • RLS can occur in children but is often misdiagnosed as "growing pains" or ADHD
  • The IRLSSG diagnostic criteria apply, though children may describe symptoms differently
  • Iron deficiency is especially common and should be assessed first
  • Treatment decisions should involve a pediatric sleep specialist

RLS in Kidney Disease

  • Very common in end-stage renal disease (up to 25-50% of dialysis patients)
  • Iron deficiency is frequent and should be aggressively treated
  • Some medications require dose adjustment for kidney function
  • Kidney transplantation often improves RLS symptoms

When Current Treatment Isn't Working

Talk to your sleep provider if:

  • Symptoms persist despite iron optimization and medication
  • You are experiencing signs of augmentation (symptoms earlier in the day, spreading to arms, worsening intensity)
  • Side effects from medication are intolerable
  • You are currently on a dopamine agonist and want to discuss transitioning to newer recommended therapies
  • Your symptoms have changed significantly

RLS management sometimes requires adjustments over time. The 2025 guidelines provide a clear framework, but treatment should be individualized to your specific situation.

Key Takeaways

  • Check iron first: ferritin and transferrin saturation for everyone with significant RLS. Treat when ferritin is 75 or below or TSAT is under 20%; IV iron when ferritin is 75 to 300 with TSAT under 45%
  • IV ferric carboxymaltose has a strong recommendation; oral iron and other IV irons are conditional options
  • Gabapentin-type medications (gabapentin, Horizant, Lyrica) are the preferred first medications, with strong recommendations
  • Dopamine agonists (Requip, Mirapex, Neupro) are no longer first-line: the guideline suggests against their standard use because of augmentation
  • If you take one now, don't stop abruptly; plan any change with your clinician
  • Avoid known triggers: caffeine, alcohol, sedating antihistamines and certain antidepressants can worsen RLS

Sources

Related RLS

Medical Disclaimer: This article is based on published sleep research and is provided for general education. Individual results vary. Consult a healthcare provider before making changes to your sleep habits, especially if you have a diagnosed sleep disorder. Read full disclaimer.